本文選題：銀翹藍芩口服液　切入點：安全性　出處：《動物醫(yī)學進展》2017年07期 　論文類型：期刊論文

【摘要】：依據獸藥研究技術指導原則,開展銀翹藍芩口服液對靶動物雞的安全性研究,為其臨床應用的安全性提供數據資料。按銀翹藍芩口服液臨床推薦劑量的1、3、5倍連續(xù)飲水給藥7d,給藥前后,逐只稱重。試驗結束后采集血液和組織器官,進行血常規(guī)、血液生化指標、臟器指數及病理組織學觀察。結果表明,與對照組相比,各給藥組雞只的體重、血常規(guī)、血液生化及臟器指數等指標差異均不顯著(P0.05),各組織器官未見明顯的病理組織學變化。說明銀翹藍芩口服液飲水給藥對靶動物雞是安全的。
[Abstract]:According to the technical guiding principle of veterinary drug research, the safety of Yinqiao Lanqin oral liquid to the target animal chicken was studied. To provide data for the safety of clinical application. According to the recommended clinical dose of Yinqiao Lanqin oral liquid, the drug was continuously administered in drinking water for 7 days, weighing one by one before and after administration. Blood and tissue organs were collected and blood routine was performed after the trial. The blood biochemical indexes, viscera index and histopathology were observed. The results showed that compared with the control group, the body weight and blood routine of the chickens in each administration group were higher than those in the control group. There was no significant difference in blood biochemistry and visceral index, but no obvious histopathological changes in tissues and organs, which indicated that Yinqiao Lanqin oral solution was safe for target chickens.
【作者單位】： 中國農業(yè)科學院蘭州畜牧與獸藥研究所/農業(yè)部獸用藥物創(chuàng)制重點實驗室/甘肅省新獸藥工程重點實驗室;
【基金】：公益性行業(yè)(農業(yè))科研專項(201303040-12)
【分類號】：S853.7

【相似文獻】

相關重要報紙文章 前3條

1 特約記者 劉良鳴;揚子江藥業(yè)擴產“藍芩口服液”[N];泰州日報;2009年

2 劉良鳴 吳德杰 賈雯雯;藍芩口服液防治手足口病獲肯定[N];中國醫(yī)藥報;2013年

3 劉良鳴 李江;藍芩口服液：“亮劍”手足口病[N];中國醫(yī)藥報;2014年

相關碩士學位論文 前1條

1 許春燕;銀翹藍芩口服液的質量標準及靶動物安全性研究[D];甘肅農業(yè)大學;2016年

，

本文編號：1568720